Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
J Med Internet Res ; 25: e44955, 2023 08 29.
Artigo em Inglês | MEDLINE | ID: mdl-37642986

RESUMO

BACKGROUND: Digital behavioral weight loss programs are scalable and effective, and they provide an opportunity to personalize intervention components. However, more research is needed to test the acceptability and efficacy of personalized digital behavioral weight loss interventions. OBJECTIVE: In a 6-month single-arm trial, we examined weight loss, acceptability, and secondary outcomes of a digital commercial weight loss program (WeightWatchers). This digital program included a personalized weight loss program based on sex, age, height, weight, and personal food preferences, as well as synchronous (eg, virtual workshops and individual weekly check-ins) and asynchronous (eg, mobile app and virtual group) elements. In addition to a personalized daily and weekly PersonalPoints target, the program provided users with personalized lists of ≥300 ZeroPoint foods, which are foods that do not need to be weighed, measured, or tracked. METHODS: We conducted a pre-post evaluation of this 6-month, digitally delivered, and personalized WeightWatchers weight management program on weight loss at 3 and 6 months in adults with overweight and obesity. The secondary outcomes included participation, satisfaction, fruit and vegetable intake, physical activity, sleep quality, hunger, food cravings, quality of life, self-compassion, well-being, and behavioral automaticity. RESULTS: Of the 153 participants, 107 (69.9%) were female, and 65 (42.5%) identified as being from a minoritized racial or ethnic group. Participants' mean age was 41.09 (SD 13.78) years, and their mean BMI was 31.8 (SD 5.0) kg/m2. Participants had an average weight change of -4.25% (SD 3.93%) from baseline to 3 months and -5.05% (SD 5.59%) from baseline to 6 months. At 6 months, the percentages of participants who experienced ≥3%, ≥5%, and ≥10% weight loss were 63.4% (97/153), 51% (78/153), and 14.4% (22/153), respectively. The mean percentage of weeks in which participants engaged in ≥1 aspects of the program was 87.53% (SD 23.40%) at 3 months and 77.67% (SD 28.69%) at 6 months. Retention was high (132/153, 86.3%), and more than two-thirds (94/140, 67.1%) of the participants reported that the program helped them lose weight. Significant improvements were observed in fruit and vegetable intake, physical activity, sleep quality, hunger, food cravings, quality of life, and well-being (all P values <.01). CONCLUSIONS: This personalized, digital, and scalable behavioral weight management program resulted in clinically significant weight loss in half (78/153, 51%) of the participants as well as improvements in behavioral and psychosocial outcomes. Future research should compare personalized digital weight loss programs with generic programs on weight loss, participation, and acceptability.


Assuntos
Terapia Comportamental , Qualidade de Vida , Adulto , Feminino , Humanos , Masculino , Etnicidade , Exercício Físico , Frutas
2.
Nutr Diabetes ; 13(1): 3, 2023 04 06.
Artigo em Inglês | MEDLINE | ID: mdl-37024467

RESUMO

BACKGROUND: The objective was to test the efficacy of a scalable, virtually delivered, diabetes-tailored weight management program on glycemic control in adults with type 2 diabetes (T2D). METHODS: This was a single arm, three-site clinical trial. Participants had baseline HbA1c between 7-11% and BMI between 27-50 kg/m2. Primary outcome was change in HbA1c at 24 weeks. Secondary outcomes were changes in body weight, waist circumference, the Diabetes Distress Scale (DDS), quality of life (IWQOL-L), and hunger (VAS). Generalized linear effects models were used for statistical analysis. RESULTS: Participants (n = 136) were 56.8 ± 0.8 y (Mean ± SEM), 36.9 ± 0.5 kg/m2, 80.2% female, 62.2% non-Hispanic white. Baseline HbA1c, weight, and total DDS score were 8.0 ± 0.09%, 101.10 ± 1.47 kg, and 2.35 ± 0.08, respectively. At week 24, HbA1c, body weight, and total DDS decreased by 0.75 ± 0.11%, 5.74 ± 0.50%, 0.33 ± 0.10 units, respectively (all p < 0.001). Also, at week 24, quality of life increased by 9.0 ± 1.2 units and hunger decreased by 14.3 ± 2.4 units, (both p < 0.0001). CONCLUSIONS: The scalable, virtually delivered T2D-tailored weight management program had favorable and clinically meaningful effects on glycemic control, body weight, and psychosocial outcomes.


Assuntos
Diabetes Mellitus Tipo 2 , Programas de Redução de Peso , Adulto , Feminino , Humanos , Masculino , Glicemia , Peso Corporal , Diabetes Mellitus Tipo 2/terapia , Diabetes Mellitus Tipo 2/complicações , Hemoglobinas Glicadas , Controle Glicêmico , Qualidade de Vida
3.
Obesity (Silver Spring) ; 29(9): 1434-1438, 2021 09.
Artigo em Inglês | MEDLINE | ID: mdl-34009723

RESUMO

OBJECTIVE: The aim of this study was to assess the impact of the coronavirus disease 2019 (COVID-19) pandemic on initial weight loss during a digital weight management program. METHODS: Participants (n = 866,192; BMI 33.6 [SD 7.4] kg/m2 ) who joined a digital weight management program (WW) in the first 30 weeks of 2020 (COVID-19 cohort) were compared with participants (n = 624,043; BMI 33.1 [SD 7.2] kg/m2 ) who joined the same program during the same time period in 2019 (control cohort). Weight change (percentage) and self-monitoring over the first 4 weeks of enrollment were compared between the cohorts. Significance was defined as meeting the criteria for a small effect (d ≥ 0.2). RESULTS: Over the 30-week enrollment period, the COVID-19 cohort experienced significantly less weight loss than the control cohort but only for 7 weeks of enrollments. The COVID-19 cohort also had fewer days of food tracking but only for 3 weeks of enrollments. There were no differences in the self-monitoring of weight and activity at any time between the two cohorts. CONCLUSIONS: Over a 30-week enrollment period, COVID-19 had negative effects on both weight loss and food self-monitoring, but the effects were short-lived. Those participating in evidence-based weight management programs can expect similar levels of initial weight loss as those experienced before the pandemic.


Assuntos
COVID-19 , Pandemias , Redução de Peso , Programas de Redução de Peso , Adulto , Estudos de Coortes , Feminino , Humanos , Masculino , Pessoa de Meia-Idade
4.
Am J Prev Med ; 58(2): 270-282, 2020 02.
Artigo em Inglês | MEDLINE | ID: mdl-31836333

RESUMO

CONTEXT: Pokémon Go is a popular mobile augmented reality game that requires players to travel to different locations to capture virtual characters. This study systematically reviews and quantifies Pokémon Go in relation to physical activity engagement among players. EVIDENCE ACQUISITION: A keyword search was conducted in PubMed, Web of Science, Scopus, EBSCO, SPORTDiscus, PsycINFO, ScienceDirect, and Cochrane Library for articles published between July 2016 and October 2018. Meta-analysis was performed to estimate the pooled effect of playing Pokémon Go on physical activity outcome. EVIDENCE SYNTHESIS: From the keyword search, 17 studies (16 observational and 1 pre-post) were identified, with a total sample of 33,108 participants. A comparison between Pokémon Go players and nonplayers and between pre- and post-play time points revealed an increase in walking duration, distance walked, and number of steps/day. Pokémon Go players were also found to engage in less sedentary behavior. Playing Pokémon Go was associated with an increase in the number of steps per day by 1,446 steps (95% CI=953, 1,939; I2=81%). CONCLUSIONS: Playing Pokémon Go was associated with a statistically significant but clinically modest increase in the number of daily steps taken among game players. One challenge for future physical activity interventions using Pokémon Go is to retain active engagement once the initial novelty wears off. Additional studies with longer follow-up periods and experimental study design are needed to assess to what extent Pokémon Go and other augmented reality games can be used to promote physical activity at the population level for a sustained time period.


Assuntos
Exercício Físico , Aplicativos Móveis/estatística & dados numéricos , Jogos de Vídeo/estatística & dados numéricos , Humanos , Jogos de Vídeo/psicologia , Caminhada
5.
Obes Rev ; 21(3): e12969, 2020 03.
Artigo em Inglês | MEDLINE | ID: mdl-31724312

RESUMO

This study reviewed evidence linking economic globalization to the obesity epidemic. Keyword/reference search was performed in PubMed, Web of Science, Cochrane Library, Scopus, EconLit, Google Scholar, and BMC Globalization and Health. A total of 16 studies were identified, in which six adopted a cross-sectional study design, nine adopted a longitudinal study design, and the remaining one adopted a case-control study design. Thirteen studies assessed the relationship between economic globalization and obesity at the country level, whereas the remaining three analyzed individual-level data. Fourteen studies found at least one aspect and/or measure of economic globalization to be positively associated with overweight/obesity, one found an inverse association, and the remaining one reported a null finding. Through market deregulation, tariff reduction, and investment liberalization, economic globalization tends to accelerate the market entry of modern food manufacturers, supermarket chains, and fast-food restaurants, resulting in substantially increased supply of high-sugar/fat energy-dense foods with enhanced variety and accessibility and reduced price. The potential impact of economic globalization on obesity through the adoption of modern workplace and domestic technologies and motorized transportation and through changes in social norms and culture were hypothesized in the literature but not empirically examined, which warrants future data-driven research.


Assuntos
Epidemias/economia , Saúde Global/economia , Internacionalidade , Obesidade/economia , Obesidade/epidemiologia , Humanos
6.
Artigo em Inglês | MEDLINE | ID: mdl-31546856

RESUMO

The purpose of this pilot study was to test the feasibility and efficacy of an iPad-enhanced aerobic exercise intervention designed to enhance wayfinding efficacy and performance and relevant cognitive functioning among middle-aged adults at risk for cognitive impairment. Twenty-seven low active adults (21 females) aged 45 to 62 years (51.22 ± 5.20) participated in a ten-week randomized controlled trial. Participants were randomized to an iPad-enhanced aerobic exercise group (experimental group) or an aerobic exercise-only group (control group) following baseline assessment. Both groups exercised at 50% to 75% of age-predicted heart rate maximum for 30 to 50 min/d, 2 d/wk for 10 weeks. During aerobic exercise, the experimental group engaged in virtual tours delivered via iPad. Baseline and post-intervention assessments of wayfinding self-efficacy, wayfinding task performance, cognitive functioning, electroencephalogram (EEG), and psychosocial questionnaires were administered. The results suggest that ten weeks of iPad-enhanced, moderately intense aerobic exercise had specific effects on wayfinding self-efficacy; however, no statistical differences were found between groups on the behavioral wayfinding task or spatial memory performance at follow-up. Performance scores on an inhibitory attentional-control cognitive assessment revealed significant differences between groups, favoring the experimental group (p < 0.05). Virtual reality-enhanced aerobic exercise may prove to be an effective method for improving cognitive function and increasing confidence to navigate real-world scenarios among individuals at risk of cognitive impairment.


Assuntos
Cognição , Disfunção Cognitiva/terapia , Terapia por Exercício/métodos , Exercício Físico , Comportamento Espacial , Computadores de Mão , Eletroencefalografia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Projetos Piloto , Resultado do Tratamento , Realidade Virtual
7.
BMC Public Health ; 19(1): 636, 2019 May 24.
Artigo em Inglês | MEDLINE | ID: mdl-31126260

RESUMO

BACKGROUND: Physical activity is effective for the prevention and treatment of chronic disease, yet insufficient evidence is available to make comparisons regarding adherence to aerobic physical activity interventions among chronic disease populations, or across different settings. The purpose of this review is to investigate and provide a quantitative summary of adherence rates to the aerobic physical activity guidelines among people with chronic conditions, as physical activity is an effective form of treatment and prevention of chronic disease. METHODS: Randomized controlled (RCTs) trials where aerobic physical activity was the primary intervention were selected from PsychInfo, PubMed, CINAHL (Cumulative Index to Nursing and Allied Health Literature), Clinical Key, and SCOPUS from 2000 to 2018. Studies were included if the program prescription aligned with the 2008 aerobic physical activity guidelines, were at least 12 weeks in length, and included adult participants living with one of three chronic diseases. The data was extracted by hand and the PRISMA (preferred reporting items for systematic review and meta-analysis) guidelines were used to evaluate risk-of-bias and quality of evidence. Data were pooled using random-effect models. The primary outcome measure was program adherence and the secondary outcome measures were dropout and setting (e.g. home vs. clinic-based). Pooled effect sizes and 95% CiIs (confidence intervals) were calculated using random-effect models. RESULTS: The literature search identified 1616 potentially eligible studies, of which 30 studies (published between 2000 and 2018, including 3,721 participants) met the inclusion criteria. Three clinical populations were targeted: cancer (n = 14), cardiovascular disease (n = 7), and diabetes (n = 9). Although not statistically significant, adherence rates varied across samples (65, 90, and 80%, respectively) whereas dropout rates were relatively low and consistent across samples (5, 4, and 3%). The average adherence rate, regardless of condition, is 77% (95% CI = 0.68, 0.84) of their prescribed physical activity treatment. The pooled adherence rates for clinic-based and home-based programs did not differ (74% [95% CI, 0.65, 0.82] and 80% [95% CI, 0.65, 0.91], respectively). CONCLUSIONS: The current evidence suggests that people with chronic conditions are capable of sustaining aerobic physical activity for 3+ months, as a form of treatment. Moreover, home-based programs may be just as feasible as supervised, clinic-based physical activity programs.


Assuntos
Reabilitação Cardíaca/métodos , Diabetes Mellitus/reabilitação , Exercício Físico , Neoplasias/reabilitação , Cooperação do Paciente/estatística & dados numéricos , Adulto , Doenças Cardiovasculares , Doença Crônica , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...